Cart
sales@molnova.com
Home - Products - Chromatin/Epigenetic - Epigenetic Reader Domain - 3-methyl-1,2-dihydroquinolin-2-one

3-methyl-1,2-dihydroquinolin-2-one

CAS No. 2721-59-7

3-methyl-1,2-dihydroquinolin-2-one( —— )

Catalog No. M28403 CAS No. 2721-59-7

3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 102 Get Quote
5MG 158 Get Quote
10MG 236 Get Quote
25MG 404 Get Quote
50MG 593 Get Quote
100MG 845 Get Quote
500MG 1692 Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    3-methyl-1,2-dihydroquinolin-2-one
  • Note
    Research use only, not for human use.
  • Brief Description
    3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.
  • Description
    3-methyl-1,2-dihydroquinolin-2-one is the first known micromolar inhibitors of the ATAD2 bromodomain.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2721-59-7
  • Formula Weight
    159.188
  • Molecular Formula
    C10H9NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1cc2ccccc2[nH]c1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Eyer P, Hell W. The metabolism of 3-benzoylpyridine. Xenobiotica. 1983 Nov;13(11):649-59. PubMed PMID: 6673376.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Molibresib besylate

    Molibresib besylate (GSK 525762C) is a selective and potent inhibitor of the bromodomain and extra-terminal (BET) family of proteins with potential anticancer activity for the study of refractory hematologic malignant diseases.

  • GSK046

    GSK046 is a potent, selective and orally active BD2 bromodomain inhibitor of the BET proteins(IC50s of 264 nM (BRD2 BD2), 98 nM (BRD3 BD2), 49 nM (BRD4 BD2) and 214 nM (BRDT BD2), respectively).

  • EML 425

    EML 425 is a potent and selective inhibitor of CREB binding protein (CBP)/p300 (IC50s: 2.9 and 1.1 μM, respectively).

Sign In Join Free